Caring Brands, Inc. (NASDAQ:CABR – Get Free Report) was the target of a large decline in short interest in the month of July. As of July 15th, there was short interest totaling 36,455 shares, a decline of 48.5% from the June 30th total of 70,819 shares. Based on an average daily trading volume, of 85,145 shares, the short-interest ratio is currently 0.4 days. Currently, 0.5% of the shares of the company are sold short.
Institutional Trading of Caring Brands
A hedge fund recently bought a new stake in Caring Brands stock. Jane Street Group LLC purchased a new stake in shares of Caring Brands, Inc. (NASDAQ:CABR – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 34,446 shares of the company’s stock, valued at approximately $30,000. Jane Street Group LLC owned approximately 0.25% of Caring Brands at the end of the most recent quarter.
Caring Brands Stock Up 3.3%
CABR stock traded up $0.05 during trading on Wednesday, reaching $1.56. 37,258 shares of the company’s stock were exchanged, compared to its average volume of 107,810. The stock has a market capitalization of $14.18 million and a price-to-earnings ratio of -2.44. The company has a fifty day simple moving average of $1.25. Caring Brands has a 1-year low of $0.71 and a 1-year high of $5.35. The company has a current ratio of 5.66, a quick ratio of 5.62 and a debt-to-equity ratio of 0.03.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings upgraded Caring Brands from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, June 11th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.
Get Our Latest Stock Report on Caring Brands
Caring Brands Company Profile
We are a wellness consumer products company. We offer several over-the-counter, or (OTC) and cosmetic, consumer products. Our method of operation is to ensure that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability. Prior to its Q3 2022 commercial launch in India as a treatment for vitiligo and psoriasis, Photocil was briefly launched in the United States markets from December 2022 until February 2023, however, was subsequently removed from the market due to insufficient sales resulting from the lack of a dedicated sales and marketing team.
Featured Stories
- Five stocks we like better than Caring Brands
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
- Meta’s AI Spending Problem Just Found a BlackRock Solution
Receive News & Ratings for Caring Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caring Brands and related companies with MarketBeat.com's FREE daily email newsletter.
